Serotonin and Premature Ejaculation: From Physiology to Patient Management

European Urology

Volumn 50, Issue 3, 2006, Pages 454-466

  Giuliano, François ^a,b   Clément, Pierre ^a  

^a Pelvipharm Laboratories   (France)

^b Department of Physical Medicine and Rehabilitation ^*  (France)

Author keywords

Dapoxetine; Neurophysiology of ejaculation; Selective serotonin reuptake inhibitor; Serotonin receptors

Indexed keywords

CLOMIPRAMINE; DAPOXETINE; FLUOXETINE; PAROXETINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADRENERGIC SYSTEM; AGITATION; ANTICHOLINERGIC EFFECT; BEHAVIOR THERAPY; BODY WEIGHT; BRAIN; CHOLINERGIC SYSTEM; CLINICAL TRIAL; COGNITIVE DEFECT; COORDINATION DISORDER; DIZZINESS; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG TOLERABILITY; EJACULATION; ERECTILE DYSFUNCTION; GAIT DISORDER; HEADACHE; HUMAN; HYPERREFLEXIA; INSOMNIA; LIBIDO DISORDER; LONG TERM CARE; MEDICAL LITERATURE; MEDLINE; MENTAL DISEASE; MYOCLONUS; NAUSEA; NERVE CELL NETWORK; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PREMATURE EJACULATION; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SEROTONINERGIC SYSTEM; SEXUAL DYSFUNCTION; SHIVERING; SKIN MANIFESTATION; SPINAL CORD; SWEATING; VOMITING;

ANIMALS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; EJACULATION; HUMANS; MALE; MODELS, BIOLOGICAL; PSYCHOTHERAPY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 33746887467     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.05.055     Document Type: Review

References (104)

1. Burnett A.L. The impact of sildenafil on molecular science and sexual health. Eur Urol 46 (2004) 9-14
2. Papaharitou S., Athanasiadis L., Nakopoulou E., et al. Erectile dysfunction and premature ejaculation are the most frequently self-reported sexual concerns: profiles of 9,536 men calling a helpline. Eur Urol 49 (2006) 557-563
3. Lewis R.W., Fugl-Meyer K.S., Bosch R., et al. Definitions, classifications and epidemiology of sexual dysfunction. In: Lue T.F., Basson R., Rosen R., Giuliano F., Khoury S., and Montorsi F. (Eds). Sexual medicine. Sexual dysfunctions in men and women (2004), Health Publication, Oxford, UK 37-72
4. Rowland D., Perelman M., Althof S., et al. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med 1 (2004) 225-232
5. Laumann E.O., Paik A., and Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281 (1999) 537-544
6. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994. p. 509-11.
7. Lue T.F., Giuliano F., Montorsi F., et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med 1 (2004) 6-23
8. Goodman R.E. The management of premature ejaculation. J Int Med Res 5 (1977) 78-79
9. Waldinger M.D., Hengeveld M.W., and Zwinderman A.H. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 151 (1994) 1377-1379
10. Waldinger M.D., and Olivier B. Utility of selective serotonin reuptake inhibitors in premature ejaculation. Curr Opin Investig Drugs 5 (2004) 743-747
11. Kara H., Aydin S., Yucel M., Agargun M.Y., Odabas O., and Yilmaz Y. The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. J Urol 156 (1996) 1631-1632
12. Althof S.E., Levine S.B., Corty E.W., Risen C.B., Stern E.B., and Kurit D.M. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry 56 (1995) 402-407
13. Pfaus J.G., and Frank A. Beach award. Homologies of animal and human sexual behaviors. Horm Behav 30 (1996) 187-200
14. Brackett N.L., Ferrell S.M., Aballa T.C., et al. An analysis of 653 trials of penile vibratory stimulation in men with spinal cord injury. J Urol 159 (1998) 1931-1934
15. McKenna K.E., Chung S.K., and McVary K.T. A model for the study of sexual function in anesthetized male and female rats. Am J Physiol 261 (1991) R1276-R1285
16. Truitt W.A., and Coolen L.M. Identification of a potential ejaculation generator in the spinal cord. Science 297 (2002) 1566-1569
17. McKenna K.E., and Nadelhaft I. The organization of the pudendal nerve in the male and female rat. J Comp Neurol 248 (1986) 532-549
18. Xu C., Yaici E.D., Conrath M., et al. Galanin and neurokinin-1 receptor immunoreactivity spinal neurons controlling the prostate and the bulbospongiosus muscle identified by transsynaptic labeling in the rat. Neuroscience 134 (2005) 1325-1341
19. Coolen L.M., Veening J.G., Wells A.B., and Shipley M.T. Afferent connections of the parvocellular subparafascicular thalamic nucleus in the rat: evidence for functional subdivisions. J Comp Neurol 463 (2003) 132-156
20. Hamson D.K., and Watson N.V. Regional brainstem expression of Fos associated with sexual behavior in male rats. Brain Res 1006 (2004) 233-240
21. Heeb M.M., and Yahr P. Anatomical and functional connections among cell groups in the gerbil brain that are activated with ejaculation. J Comp Neurol 439 (2001) 248-258
22. Meisel R., and Sachs B. The physiology of male sexual behavior. In: Knobil E., and Neill J. (Eds). The physiology of reproduction (1994), Raven, New York 3-105
23. Coolen L.M., Peters H.J., and Veening J.G. Anatomical interrelationships of the medial preoptic area and other brain regions activated following male sexual behavior: a combined Fos and tract-tracing study. J Comp Neurol 397 (1998) 421-435
24. Simerly R.B., and Swanson L.W. Projections of the medial preoptic nucleus: a Phaseolus vulgaris leucoagglutinin anterograde tract-tracing study in the rat. J Comp Neurol 270 (1988) 209-242
25. Rizvi T.A., Ennis M., and Shipley M.T. Reciprocal connections between the medial preoptic area and the midbrain periaqueductal gray in rat: A WGA-HRP and PHA-L study. J Comp Neurol 315 (1992) 1-15
26. Murphy A.Z., Rizvi T.A., Ennis M., and Shipley M.T. The organization of preoptic-medullary circuits in the male rat: evidence for interconnectivity of neural structures involved in reproductive behavior, antinociception and cardiovascular regulation. Neuroscience 91 (1999) 1103-1116
27. Luiten P.G., ter Horst G.J., Karst H., and Steffens A.B. The course of paraventricular hypothalamic efferents to autonomic structures in medulla and spinal cord. Brain Res 329 (1985) 374-378
28. Saper C.B., Loewy A.D., Swanson L.W., and Cowan W.M. Direct hypothalamo-autonomic connections. Brain Res 117 (1976) 305-312
29. Canteras N.S., Simerly R.B., and Swanson L.W. Organization of projections from the medial nucleus of the amygdala: a PHAL study in the rat. J Comp Neurol 360 (1995) 213-245
30. Yasui Y., Saper C.B., and Cechetto D.F. Calcitonin gene-related peptide (CGRP) immunoreactive projections from the thalamus to the striatum and amygdala in the rat. J Comp Neurol 308 (1991) 293-310
31. Marson L., and McKenna K.E. A role for 5-hydroxytryptamine in descending inhibition of spinal sexual reflexes. Exp Brain Res 88 (1992) 313-320
32. Marson L., and McKenna K.E. CNS cell groups involved in the control of the ischiocavernosus and bulbospongiosus muscles: a transneuronal tracing study using pseudorabies virus. J Comp Neurol 374 (1996) 161-179
33. Marson L. Lesions of the periaqueductal gray block the medial preoptic area-induced activation of the urethrogenital reflex in male rats. Neurosci Lett 367 (2004) 278-282
34. Murphy A.Z., and Hoffman G.E. Distribution of gonadal steroid receptor-containing neurons in the preoptic-periaqueductal gray-brainstem pathway: a potential circuit for the initiation of male sexual behavior. J Comp Neurol 438 (2001) 191-212
35. Holstege G., Georgiadis J.R., Paans A.M., Meiners L.C., van der Graaf F.H., and Reinders A.A. Brain activation during human male ejaculation. J Neurosci 23 (2003) 9185-9193
36. Arnow B.A., Desmond J.E., Banner L.L., et al. Brain activation and sexual arousal in healthy, heterosexual males. Brain 125 (2002) 1014-1023
37. Holstege G. Central nervous system control of ejaculation. World J Urol 23 (2005) 109-114
38. Perretti A., Catalano A., Mirone V., et al. Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation. Urology 61 (2003) 623-628
39. Hull E.M., Muschamp J.W., and Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiol Behav 83 (2004) 291-307
40. Waldinger M.D., Berendsen H.H., Blok B.F., Olivier B., and Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 92 (1998) 111-118
41. Marson L., and McKenna K.E. The identification of a brainstem site controlling spinal sexual reflexes in male rats. Brain Res 515 (1990) 303-308
42. Renyi L. Ejaculations induced by p-chloroamphetamine in the rat. Neuropharmacology 24 (1985) 697-704
43. Yonezawa A., Watanabe C., Ando R., et al. Characterization of p-chloroamphetamine-induced penile erection and ejaculation in anesthetized rats. Life Sci 67 (2000) 3031-3039
44. Fernandez-Guasti A., Escalante A.L., Ahlenius S., Hillegaart V., and Larsson K. Stimulation of 5-HT1A and 5-HT1B receptors in brain regions and its effects on male rat sexual behaviour. Eur J Pharmacol 210 (1992) 121-129
45. Hillegaart V., Ahlenius S., and Larsson K. Region-selective inhibition of male rat sexual behavior and motor performance by localized forebrain 5-HT injections: a comparison with effects produced by 8-OH-DPAT. Behav Brain Res 42 (1991) 169-180
46. Verma S., China G.S., Mohan Kumar V., and Singh B. Inhibition of male sexual behavior by serotonin application in the medial preoptic area. Physiol Behav 46 (1989) 327-330
47. Hillegaart V., Ahlenius S., and Larsson K. Effects of local application of 5-HT into the median and dorsal raphe nuclei on male rat sexual and motor behavior. Behav Brain Res 33 (1989) 279-286
48. Hillegaart V., and Ahlenius S. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181. Br J Pharmacol 125 (1998) 1733-1743
49. Rowland D.L., and Houtsmuller E.J. 8-OH-DPAT interacts with sexual experience and testosterone to affect ejaculatory response in rats. Pharmacol Biochem Behav 60 (1998) 143-149
50. Sharp T., Bramwell S.R., and Grahame-Smith D.G. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 96 (1989) 283-290
51. Bonvento G., Scatton B., Claustre Y., and Rouquier L. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neurosci Lett 137 (1992) 101-104
52. Clement P., Bernabe J., Kia H.K., Alexandre L., and Giuliano F. D2-like receptors mediate the expulsion phase of ejaculation elicited by 8-hydroxy-2-(di-N-propylamino)tetralin in rats. J Pharmacol Exp Ther 316 (2006) 830-834
53. Matuszewich L., Lorrain D.S., Trujillo R., Dominguez J., Putnam S.K., and Hull E.M. Partial antagonism of 8-OH-DPAT'S effects on male rat sexual behavior with a D2, but not a 5-HT1A, antagonist. Brain Res 820 (1999) 55-62
54. Ahlenius S., and Larsson K. Evidence for an involvement of 5-HT1B receptors in the inhibition of male rat ejaculatory behavior produced by 5-HTP. Psychopharmacology (Berl) 137 (1998) 374-382
55. Foreman M.M., Hall J.L., and Love R.L. The role of the 5-HT2 receptor in the regulation of sexual performance of male rats. Life Sci 45 (1989) 1263-1270
56. Blier P., and de Montigny C. Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci 3 (1983) 1270-1278
57. Chaput Y., Blier P., and de Montigny C. In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J Neurosci 6 (1986) 2796-2801
58. Blier P., Chaput Y., and de Montigny C. Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 337 (1988) 246-254
59. Schafer W.R. How do antidepressants work? Prospects for genetic analysis of drug mechanisms. Cell 98 (1999) 551-554
60. Al Damluji S. The mechanism of action of antidepressants: a unitary hypothesis based on transport-p. Curr Drug Targets CNS Neurol Disord 3 (2004) 201-216
61. Fuller R.W. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci 55 (1994) 163-167
62. de Montigny C., Blier P., Caille G., and Kouassi E. Pre- and postsynaptic effects of zimelidine and norzimelidine on the serotoninergic system: single cell studies in the rat. Acta Psychiatr Scand Suppl 290 (1981) 79-90
63. Waldinger M.D., Schweitzer D.H., and Olivier B. On-demand SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. J Sex Med 2 (2005) 121-131
64. Sprouse J., Braselton J., Reynolds L., Clarke T., and Rollema H. Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies. Synapse 41 (2001) 49-57
65. Sprouse J., Clarke T., Reynolds L., Heym J., and Rollema H. Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo. Neuropsychopharmacology 14 (1996) 225-231
66. Anderson G.M. Peripheral and central neurochemical effects of the selective serotonin reuptake inhibitors (SSRIs) in humans and nonhuman primates: assessing bioeffect and mechanisms of action. Int J Dev Neurosci 22 (2004) 397-404
67. Anderson G.M., Barr C.S., Lindell S., Durham A.C., Shifrovich I., and Higley J.D. Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey. Psychopharmacology (Berl) 178 (2005) 339-346
68. Frank J.L., Hendricks S.E., and Olson C.H. Multiple ejaculations and chronic fluoxetine: effects on male rat copulatory behavior. Pharmacol Biochem Behav 66 (2000) 337-342
69. Cantor J.M., Binik Y.M., and Pfaus J.G. Chronic fluoxetine inhibits sexual behavior in the male rat: reversal with oxytocin. Psychopharmacology (Berl) 144 (1999) 355-362
70. Waldinger M.D., van De Plas A., Pattij T., et al. The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology (Berl) 160 (2002) 283-289
71. Mos J., Mollet I., Tolboom J.T., Waldinger M.D., and Olivier B. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat. Eur Neuropsychopharmacol 9 (1999) 123-135
72. Yells D.P., Prendergast M.A., Hendricks S.E., and Nakamura M. Fluoxetine-induced inhibition of male rat copulatory behavior: modification by lesions of the nucleus paragigantocellularis. Pharmacol Biochem Behav 49 (1994) 121-127
73. Gengo PJ, Gravitt K, Marson L. Actions of dapoxetine on ejaculation and sexual behaviour in rats. European Society for Sexual Medicine, 8th Congress Copenhagen; 2006.
74. Waldinger M.D. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int J Impot Res 15 (2003) 309-313
75. Haensel S.M., Klem T.M., Hop W.C., and Slob A.K. Fluoxetine and premature ejaculation: a double-blind, crossover, placebo-controlled study. J Clin Psychopharmacol 18 (1998) 72-77
76. Lee H.S., Song D.H., Kim C.H., and Choi H.K. An open clinical trial of fluoxetine in the treatment of premature ejaculation. J Clin Psychopharmacol 16 (1996) 379-382
77. Forster P., and King J. Fluoxetine for premature ejaculation. Am J Psychiatry 151 (1994) 1523
78. Power-Smith P. Beneficial sexual side-effects from fluoxetine. Br J Psychiatry 164 (1994) 249-250
79. Biri H., Isen K., Sinik Z., Onaran M., Kupeli B., and Bozkirli I. Sertraline in the treatment of premature ejaculation: a double-blind placebo controlled study. Int Urol Nephrol 30 (1998) 611-615
80. Mendels J. Sertraline for premature ejaculation. J Clin Psychiatry 56 (1995) 591
81. Wise T.N. Sertraline as a treatment for premature ejaculation. J Clin Psychiatry 55 (1994) 417
82. Balbay M.D., Yildiz M., Salvarci A., Ozsan O., and Ozbek E. Treatment of premature ejaculation with sertralin. Int Urol Nephrol 30 (1998) 81-83
83. Ludovico G.M., Corvasce A., Pagliarulo G., Cirillo-Marucco E., Marano A., and Pagliarulo A. Paroxetine in the treatment of premature ejaculation. Br J Urol 77 (1996) 881-882
84. McMahon C.G., and Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Int J Impot Res 11 (1999) 241-245
85. Murat B.M., Atan A., Yildiz M., Baykam M., and Aydoganli L. Comparison of sertraline to fluoxetine with regard to their efficacy and side effects in the treatment of premature ejaculation. Arch Esp Urol 52 (1999) 1008-1011
86. Waldinger M.D., Hengeveld M.W., Zwinderman A.H., and Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 18 (1998) 274-281
87. McMahon C.G. Ejaculatory dysfunction. In: Seftel A.D., Padman-Nathan H., McMahon C.G., Giuliano F., and Althof S. (Eds). Male and female sexual dysfunction (2004), Mosby, London 50-76
88. Abdel-Hamid I.A., El Naggar E.A., and El Gilany A.H. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 13 (2001) 41-45
89. McMahon C.G., and Touma K. Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J Urol 161 (1999) 1826-1830
90. Waldinger M.D., Zwinderman A.H., and Olivier B. On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. Eur Urol 46 (2004) 510-516
91. Pryor J.L., Althof S.E., Steidle C., Miloslavsky M., and Kell S. Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation. J Urol 173 (2005) 201
92. Althof S.E. Psychological treatment strategies for rapid ejaculation: rationale, practical aspects, and outcome. World J Urol 23 (2005) 89-92
93. Goldstein B.J., and Goodnick P.J. Selective serotonin reuptake inhibitors in the treatment of affective disorders, III. Tolerability, safety and pharmacoeconomics. J Psychopharmacol 12 (1998) S55-S87
94. Tamam L., and Ozpoyraz N. Selective serotonin reuptake inhibitor discontinuation syndrome: a review. Adv Ther 19 (2002) 17-26
95. Haddad P. The SSRI discontinuation syndrome. J Psychopharmacol 12 (1998) 305-313
96. Black K., Shea C., Dursun S., and Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci 25 (2000) 255-261
97. Nelson E.B., Keck P.E., and McElroy S.L. Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisetron. J Clin Psychiatry 58 (1997) 496-497
98. Lane R., and Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 17 (1997) 208-221
99. Montague D.K., Jarow J., Broderick G.A., Dmochowski R.R., Heaton J.P., Lue T.F., et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 172 (2004) 290-294
100. Semans J.H. Premature ejaculation: a new approach. South Med J 49 (1956) 353-358
101. Master W.H., and Johnson V.E. Human sexual inadequacy (1970), Little Brown, Boston p. 509-41
102. Clarke M., and Parry L. Premature ejaculation treated by the dual sex team method of Masters and Johnson. Aust N Z J Psychiatry 7 (1973) 200-205
103. De Amicis L.A., Goldberg D.C., LoPiccolo J., Friedman J., and Davies L. Clinical follow-up of couples treated for sexual dysfunction. Arch Sex Behav 14 (1985) 467-489
104. Althof S.E. Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation. J Urol 175 (2006) 842-848